radioligand

Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase
BioSpace
Tue, 10/3/23 - 11:59 am
Eli Lilly
oncology
M&A
Point Biopharma
radioligand
Bicycle, Novartis Ink Oncology Deal Worth up to $1.7B
BioSpace
Tue, 03/28/23 - 11:30 am
Bicycle Therapeutics
Novartis
drug discovery
oncology
radioligand
Two Novartis sites stop manufacturing cancer therapies after quality issues
Endpoints
Thu, 05/5/22 - 11:21 pm
Novartis
drug manufacturing
radioligand
Novartis' radiopharma drug wins approval in tough-to-treat prostate cancer patients
Endpoints
Wed, 03/23/22 - 11:01 pm
Novartis
Lu-PSMA-617
radioligand
prostate cancer
Oncologists on board for Novartis' prostate cancer radiotherapy, but logistics could hit uptake: survey
Fierce Pharma
Wed, 02/23/22 - 10:29 am
Novartis
prostate cancer
oncologists
radioligand
177Lu-PSMA-617
Just months after SPAC reverse merger, Point Biopharma ups the ante at Indianapolis manufacturing site
Endpoints
Fri, 06/4/21 - 10:38 am
Point Biopharma
SPAC
drug manufacturing
radioligand
Novartis Breaks Through with Radioligand Therapy for Prostate Cancer
BioSpace
Fri, 06/4/21 - 10:36 am
ASCO 2021
prostate cancer
radioligand
Novartis' radioligand hits goal in phase 3 prostate cancer trial
Fierce Biotech
Tue, 03/23/21 - 10:29 am
Novartis
radioligand
177Lu-MSMA-617
prostate cancer
clinical trials